CAS: 936221-33-9 - CG200745
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ivaltinostat REF: 4Z-I-144001CAS: 936221-33-9 | - - - | To inquire | Wed 11 Dec 24 |
 | CG 200745 REF: 3D-LMB22133CAS: 936221-33-9 | Min. 95% | To inquire | Wed 15 Jan 25 |
 | Ivaltinostat REF: TM-T14936CAS: 936221-33-9 | 98% | 1,001.00 €~2,619.00 € | Wed 22 Jan 25 |
Ref: 4Z-I-144001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
CG 200745
CAS:936221-33-9
CG 200745 is a histone protein-conjugate that inhibits the activity of mammalian target of rapamycin …
Formula:
C24H33N3O4
Purity:
Min. 95%
Molecular weight:
427.5 g/mol
Ref: 3D-LMB22133
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Ivaltinostat
CAS:936221-33-9
CG-200745 is a potent inhibitor of HDAC. CG200745 induces apoptosis and also inhibits the deacetylation …
Formula:
C24H33N3O4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
427.54
Ref: TM-T14936
| 25mg | 1,549.00 € | ||
| 50mg | 2,039.00 € | ||
| 100mg | 2,619.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
